Skip to content

Effect of green tea on treatment of lupus

The effect of green tea extract on some inflammatory biomarkers(IL 6, IL1ß,TNF a,CRP), serum total antioxidant capacity(TAC), MDA and Disease activity in patients with Systemic lupus erythematous

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015091924059N2
Enrollment
76
Registered
2016-02-20
Start date
2015-09-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythmatous. Systemic Lupus Erythematosus, unspecified

Interventions

Intervention 1: Intervention group: Patients are given daily dose of 1000mg aqueous green tea extract (of 6 grams of dried green tea leaf) in the form of 2 capsules( 500 mg) for three months. Interven
Treatment - Drugs
Intervention group: Patients are given daily dose of 1000mg aqueous green tea extract (of 6 grams of dried green tea leaf) in the form of 2 capsules( 500 mg) for three months.
Control group : Patients in Control group receive daily dose of 1000 mg cellulose in the form of 2 capsules ( 500 mg) for three months

Sponsors

Vice chancellor for research , Ahvaz university of medical sceinces
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria : patients older than 15 years who have had 4 diagnosis criteria’s of lupus. These include clinical and immunological criteria. Exclusion criteria: patients with other autoimmune diseases; infectious or liver disease; patients with creatinine higher than 2.5 and women who are pregnant.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Disease Activity. Timepoint: Three months after starting of intervention. Method of measurement: Determination of disease activity is done through SLEDAI ( systemic lupus erythmatous disease activity index ) questionnare.

Secondary

MeasureTime frame
(IL6,IL1ß, TNFa,CRP),MDA ,serum total antioxidant capacity. Timepoint: At baseline and after three months of intervention. Method of measurement: Comparison of variables of each group before and after intervention.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZahra Shamekhi

Ahvaz university of medical sceinces

zshamekhi2007@gmail.com;z_shamekhi2007@yahoo.com;shamekhi.z@ajums.ac.ir+98 61 3336 1984

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026